Jane Street’s Incannex Healthcare IXHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-49,728
Closed -$534K 12278
2025
Q4
$534K Buy
49,728
+42,046
+547% +$486K ﹤0.01% 7522
2025
Q3
$107K Buy
+7,682
New +$125K ﹤0.01% 10110
2025
Q1
Sell
-1,576
Closed -$100K 10018
2024
Q4
$100K Buy
+1,576
New +$94.7K ﹤0.01% 8764
2024
Q2
Sell
-681
Closed -$73.4K 9785
2024
Q1
$73.4K Buy
+681
New +$81.9K ﹤0.01% 8647
2023
Q3
Sell
-97
Closed -$21.4K 9001
2023
Q2
$21.4K Sell
97
-47
-33% -$11.4K ﹤0.01% 8356
2023
Q1
$38.2K Sell
144
-69
-32% -$23.3K ﹤0.01% 8516
2022
Q4
$71.7K Buy
213
+59
+38% +$27K ﹤0.01% 8248
2022
Q3
$81K Buy
+154
New +$80.6K ﹤0.01% 8748
2022
Q2
Sell
-315
Closed -$378K 10254
2022
Q1
$378K Buy
+315
New +$520K ﹤0.01% 7987

Other funds holding IXHL

Jane Street's IXHL Position: Q1 2026 in Review

Jane Street sold out of Incannex Healthcare (IXHL) in Q1 2026, closing a stake of 49,728 shares — an estimated $534K sold.

Jane Street first reported a position in IXHL in Q1 2022 and held it in 9 quarters. The position peaked at $534K in Q4 2025. 21 funds tracked by Wall St. Rank hold IXHL as of Q1 2026.

  • Jane Street reported no remaining Incannex Healthcare position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 49,728 Incannex Healthcare shares in Q1 2026, an estimated $534K.
  • Jane Street first reported a position in Incannex Healthcare in Q1 2022 and held it in 9 quarters.
  • Jane Street's Incannex Healthcare position peaked at $534K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Incannex Healthcare as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.